1-10 of 10
Wolfgang-Ulrich Knauf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Wolfgang Ulrich Knauf, MD, Wolfgang Abenhardt, MD, Arnd Nusch, MD, Renate Grugel, Norbert Marschner, MD
Journal: Blood
Blood (2012) 120 (21): 4605.
https://doi.org/10.1182/blood.V120.21.4605.4605
Published: 2012
Journal Articles

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Wolfgang Ulrich Knauf, MD, Wolfgang Abenhardt, MD, Arnd Nusch, MD, Renate Grugel, Norbert Marschner, MD
Journal: Blood
Blood (2012) 120 (21): 3666.
https://doi.org/10.1182/blood.V120.21.3666.3666
Published: 2012
Journal Articles

Bendamustine Induces Higher Remission Rates, Prolongs Progression Free Survival as Well as Time to Next Treatment, and Improves Overall Survival for Patients In Complete Remission without Compromising Quality of Life When Compared to Chlorambucil In First Line Treatment of Chronic Lymphocytic Leukemia

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Marina Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Françoise Huguet, MD, Ilaria Del Guidice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo
Journal: Blood
Blood (2010) 116 (21): 2449.
https://doi.org/10.1182/blood.V116.21.2449.2449
Published: 2010
Journal Articles

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, MD, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Francoise Huguet, MD, Ilaria Del Giudice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo, MD
Journal: Blood
Blood (2009) 114 (22): 2367.
https://doi.org/10.1182/blood.V114.22.2367.2367
Published: 2009
Journal Articles

Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial.

Peter Dreger, Hartmut Döhner, Hildegard Greinix, MD, Fabienne McClanahan, MD, Manfred Hensel, Bernd Hertenstein, Ulrich Dührsen, MD, PhD, Markus Hentrich, Lorenz Trümper, Ruth Sonnen, Bertold Emmerich, Wolfgang Ulrich Knauf, Georg Hopfinger, MD, Michael Hallek, Michael Kneba, MD, PhD, Norbert Schmitz, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2009) 114 (22): 879.
https://doi.org/10.1182/blood.V114.22.879.879
Published: 2009
Journal Articles

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.

Wolfgang Ulrich Knauf, Toshko Lissitchkov, Ali Aldaoud, Anna Liberati, Javier Loscertales, Roul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, Liana Gercheva, Stefan Goranov, MD, Martin Becker, Klaus Hoeffken, Francoise Huguet, Robert Foa, MD, Karlheinz Merkle, Marco Montillo
Journal: Blood
Blood (2008) 112 (11): 2091.
https://doi.org/10.1182/blood.V112.11.2091.2091
Published: 2008
Journal Articles

Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study.

Wolfgang Ulrich Knauf, MD, Toshko Lissichkov, M.D., Ali Aldaoud, M.D., Raoul Herbrecht, M.D., Anna Marina Liberati, M.D., Javier Loscertales, M.D., Gunnar Juliusson, M.D., Christian Dittrich, M.D., Karlheinz Merkle, M.D.
Journal: Blood
Blood (2007) 110 (11): 2043.
https://doi.org/10.1182/blood.V110.11.2043.2043
Published: 2007
Journal Articles

Final Results of a Prospective, Non-Interventional Study on Bortezomib (Velcade®, VEL) in the Treatment of Multiple Myeloma (MM) in Office-Based Hematology Units (OBH).

Wolfgang Ulrich Knauf, MD, Burkhard Otremba, MD, Friedrich Overkamp, MD, Susanne Bammer, PhD, Ralf Angermund, MD
Journal: Blood
Blood (2006) 108 (11): 5109.
https://doi.org/10.1182/blood.V108.11.5109.5109
Published: 2006
Journal Articles

Bendamustine Versus Chlorambucil in Treatment-Naive B-CLL Patients.

Wolfgang Ulrich Knauf, M.D., Toshko Lissitchkov, M.D., Raoul Herbrecht, M.D., Javier Loscertales, M.D., Ali Aldaoud, M.D., Karlheinz Merkle, M.D.
Journal: Blood
Blood (2004) 104 (11): 4817.
https://doi.org/10.1182/blood.V104.11.4817.4817
Published: 2004
Journal Articles

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Holger Schulz, Saskia Karina Klein, Ute Rehwald, Marcel Reiser, Axel Hinke, Wolfgang-Ulrich Knauf, Walter-Erich Aulitzky, Manfred Hensel, Michael Herold, Dieter Huhn, Michael Hallek, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2002) 100 (9): 3115–3120.
https://doi.org/10.1182/blood-2002-03-0972
Published: 2002